Vera Therapeutics, Inc. (VERA) Misses Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $38.20 -0.6%
EPS Growth %: -35.0%
Financial Fact:
Product revenues: 280K
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -35.0%
Financial Fact:
Product revenues: 280K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q3 EPS of ($1.26), $0.11 worse than the analyst estimate of ($1.15).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- BioNxt closes $2M private placement at $0.33 per unit
- Morgan Stanley Private Credit Fund Caps Redemptions At 5%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
